ARCUTIS BIOTHERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.865 USD | -3.73% |
|
-11.43% | +143.50% |
| May. 28 | Johnson & Johnson Acquires Experimental Eczema Drug for $1.25 Billion | MT |
| May. 15 | Needham Adjusts Price Target on Arcutis Biotherapeutics to $18 From $16, Maintains Buy Rating | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 9.920 | 12.53 | 11.77 |
| Spread/Res. | -20.72% | -37.23% | -33.18% |
| Spread/Supp. | +0.32% | +63.17% | +66.10% |
| Support | 7.840 | 4.820 | 4.735 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ARQT Stock
- Charts Arcutis Biotherapeutics, Inc.
